Evidence map›Paper›PMID 40464687›Full record

ArticleNucleic acids research2025

A post-assembly conformational change makes the SARS-CoV-2 polymerase elongation-competent.

Misha Klein, Arnab Das, Subhas C Bera, Thomas K Anderson, Dana Kocincova, Hery W Lee, Bing Wang, Flavia S Papini, John C Marecki, Jamie J Arnold and 7 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Misha KleinDepartment of Physics and Astronomy, and LaserLaB Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1100, 1081 HZ Amsterdam, The Netherlands.
Arnab DasDepartment of Physics and Astronomy, and LaserLaB Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1100, 1081 HZ Amsterdam, The Netherlands.
Subhas C BeraJunior Research Group 2, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Cauerstr. 3, 91058 Erlangen, Germany.
Thomas K AndersonDepartment of Biochemistry and Institute for Molecular Virology, University of Wisconsin-Madison, Madison, WI 53706, United States.
Dana KocincovaDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Hery W LeeDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Bing WangDepartment of Microbiology and The Center for RNA Biology, The Ohio State University, Columbus, OH 43210, United States.
Flavia S PapiniJunior Research Group 2, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Cauerstr. 3, 91058 Erlangen, Germany.
John C MareckiDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
Jamie J ArnoldDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, United States.
Craig E CameronDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, United States.
Kevin D RaneyDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.ORCID 0000-0002-7290-0206
Irina ArtsimovitchDepartment of Microbiology and The Center for RNA Biology, The Ohio State University, Columbus, OH 43210, United States.ORCID 0000-0002-8604-0980
Mathias GötteDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Robert N KirchdoerferDepartment of Biochemistry and Institute for Molecular Virology, University of Wisconsin-Madison, Madison, WI 53706, United States.ORCID 0000-0002-5974-2709
Martin DepkenDepartment of Bionanoscience, Kavli Institute of Nanoscience, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands.
David DulinDepartment of Physics and Astronomy, and LaserLaB Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1100, 1081 HZ Amsterdam, The Netherlands.ORCID 0000-0003-4209-0377

Funding

Translation Accelerator CoreU19AI171421 · NIAID · STANFORD UNIVERSITY · PI JEFFREY S GLENN · 2022 to 2026
$93.4M
Research Project 1: Coronavirus antiviral lead development and combination testingU19AI171292 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, WILLSON, TIMOTHY M · 2022 to 2022
$65.5M
Mechnanism of transcript elongation control by RfaHR01GM067153 · NIGMS · OHIO STATE UNIVERSITY · PI IRINA ARTSIMOVITCH · 2003 to 2026
$8.0M
Coronavirus Genome ReplicationR01AI161841 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jamie Jon Arnold, CRAIG E. CAMERON · 2021 to 2026
$3.4M
Alberta Ministry of Technology and InnovationGerman Research Foundation 024.003.019German Research Foundation DFG-DU-1872/4-1Interdisciplinary Center for Clinical Research (IZKF)NIAID NIH HHS R01 AI161841NIAID NIH HHS U19 AI171292NIAID NIH HHS U19 AI171421NIGMS NIH HHS R01 GM067153NIGMS NIH HHS R35-GM12260NIH HHS R01 AI161841-01NIH HHS R01 GM067153NIH HHS U19 AI171292NIH HHS U19 AI171421NWO OCENW.XL21.XL21.115OCW
6 · The paper itself

Abstract

Coronaviruses (CoVs) encode 16 nonstructural proteins (nsps), most of which form the replication-transcription complex (RTC). The RTC contains a core composed of one nsp12 RNA-dependent RNA polymerase (RdRp), two nsp8s, and one nsp7. The core RTC recruits other nsps to synthesize all viral RNAs within the infected cell. While essential for viral replication, the mechanism by which the core RTC assembles into a processive polymerase remains poorly understood. We show that the core RTC preferentially assembles by first having nsp12-polymerase bind to the RNA template, followed by the subsequent association of nsp7 and nsp8. Once assembled on the RNA template, the core RTC requires hundreds of seconds to undergo a conformational change that enables processive elongation. In the absence of RNA, the (apo-)RTC requires several hours to adopt its elongation-competent conformation. We propose that this obligatory activation step facilitates the recruitment of additional nsps essential for efficient viral RNA synthesis and may represent a promising target for therapeutic interventions.

Indexed as

Coronavirus RNA-Dependent RNA PolymeraseSARS-CoV-2Viral Nonstructural ProteinsHumansProtein ConformationRNA-Dependent RNA PolymeraseRNA, ViralTranscription Elongation, GeneticVirus ReplicationCoronavirus RNA-Dependent RNA PolymeraseNS8 protein, SARS-CoV-2NSP12 protein, SARS-CoV-2ORF1ab polyprotein, SARS-CoV-2RNA-Dependent RNA PolymeraseRNA, ViralViral Nonstructural Proteins

Identifiers

PMID40464687
PMCPMC12135201

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.